New York State Common Retirement Fund
AQST icon

New York State Common Retirement Fund’s Aquestive Therapeutics AQST Stock Holding History

New York State Common Retirement Fund’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Hold
27,300
– – ﹤0.01% 2618
2026
Q1 		$113K Hold
27,300
– – ﹤0.01% 2469
2025
Q4 		$176K Buy
27,300
+15,100
+124% +$94.1K ﹤0.01% 2345
2025
Q3 		$68.2K Hold
12,200
– – ﹤0.01% 2845
2025
Q2 		$40.4K Hold
12,200
– – ﹤0.01% 2997
2025
Q1 		$35.4K Hold
12,200
– – ﹤0.01% 2874
2024
Q4 		$43.4K Buy
12,200
+10,700
+713% +$49.3K ﹤0.01% 2887
2024
Q3 		$7.47K Sell
1,500
-37,200
-96% -$145K ﹤0.01% 3127
2024
Q2 		$101K Buy
+38,700
New +$129K ﹤0.01% 2833
2021
Q3 		– Sell
-159
Closed -$1K – 3336
2021
Q2 		$1K Sell
159
-9,841
-98% -$39.3K ﹤0.01% 3360
2021
Q1 		$52K Hold
10,000
– – ﹤0.01% 3209
2020
Q4 		$54K Hold
10,000
– – ﹤0.01% 3175
2020
Q3 		$49K Sell
10,000
-8,800
-47% -$57.5K ﹤0.01% 3142
2020
Q2 		$91K Buy
+18,800
New +$86.6K ﹤0.01% 3021
2019
Q2 		– Sell
-4,500
Closed -$31K – 3241
2019
Q1 		$31K Hold
4,500
– – ﹤0.01% 3107
2018
Q4 		$28K Buy
+4,500
New +$56.8K ﹤0.01% 3137

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EAM
Everstar Asset Management Mooresville, North Carolina $207M AUM 18.14% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

New York State Common Retirement Fund's AQST Position: Q2 2026 in Review

New York State Common Retirement Fund held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 27,300 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

New York State Common Retirement Fund first reported a position in AQST in Q4 2018 and has held it in 16 quarters since. The position peaked at $176K in Q4 2025. 41 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • New York State Common Retirement Fund held 27,300 shares of Aquestive Therapeutics worth $114K as of Q2 2026.
  • New York State Common Retirement Fund left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2618 holding.
  • New York State Common Retirement Fund first reported a position in Aquestive Therapeutics in Q4 2018 and has held it in 16 quarters since.
  • New York State Common Retirement Fund's Aquestive Therapeutics position peaked at $176K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.